You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Attention Score in Context
| Title |
Ravulizumab use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice
|
|---|---|
| Published in |
Frontiers in Neurology, June 2024
|
| DOI | 10.3389/fneur.2024.1378080 |
| Pubmed ID | |
| Authors |
Nakul Katyal, Raghav Govindarajan, Neelam Goyal, Suraj Muley, Srikanth Muppidi |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 July 2024.
All research outputs
#5,054,583
of 26,227,947 outputs
Outputs from Frontiers in Neurology
#3,979
of 14,908 outputs
Outputs of similar age
#42,719
of 219,466 outputs
Outputs of similar age from Frontiers in Neurology
#15
of 105 outputs
Altmetric has tracked 26,227,947 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 14,908 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 219,466 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 105 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.